Therapeutic Safety and Efficacy of REP 9AC (REP 2055) in HBV or HCV Infected Patients

Clinical trial NCT02646163 · COMPLETED

Trial details

NCT number: NCT02646163
Sponsor: Replicor Inc.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Hepatitis B, Chronic

Start date: 2009-01-01
Primary completion: 2012-12-01
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.